Ettayapurum V Sunderrajan, MD
Pulmonary Disease · San Jose
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 5
- 2 carriers
- Office
- 1
Offices
1 location · County of Santa Clara · 1,000 clinicians in this group
Looking this up.
Hospitals listed: Santa Clara Valley Medical Center. That is not proof they admit you there this week.
Plans that list them
5 plans · 2 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Sunderrajan’s office at (408) 885-5000 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
5 of 5 plans
| SCAN Balance (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Classic (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN MyChoice (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
California Medical Board record
Licence A42385 · Current
Licensed to practise in California · since 1985 · expires 2027-05-31 · Osmania University, Osmania Medical College.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Santa Clara Valley Medical CenterSan Jose, CAAcute Care Hospital · Government - Local · Has an emergency department · Birthing-friendlyPart of Santa Clara Valley Health and Hospital System, which runs 3 hospitalsPatients rate it 3 of 5 · 70% would definitely recommend itOverall rating: 2 of 5 starsWorse than the national rate — SSI - Colon Surgery: 2.572, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.563, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.256, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0.369, Oct 2024 – Sep 2025
See every measure and the patient survey for Santa Clara Valley Medical Center
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 1 worse of 8 measures. Readmissions: 0 better, 10 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| SSI - Colon SurgeryInfections | 2.572 | Worse | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.563 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.256 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.369 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.25 (0.3 to 2.2) · 1,535 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.07 (0.76 to 1.38) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 214.59 (167.38 to 261.8) · 108 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.8 · 41 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6 · 141 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.2 · 124 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.3 · 501 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.9 · 653 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.1 · 348 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3 · 4,502 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.24 (0.04 to 0.43) · 9,014 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.34 (0.15 to 0.52) · 9,216 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.54 (2.51 to 6.58) · 1,421 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.54 (0 to 3.2) · 288 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.66 to 3.56) · 1,446 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 11.61 (4.09 to 19.14) · 294 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 7.29 (3.39 to 11.2) · 299 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.9 (0.45 to 3.36) · 333 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.23 (0 to 0.78) · 7,538 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 5.4 · 94 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.735 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 2.573 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.6 · 185 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.1 · 951 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 56.3 · 128 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 6.4 · 644 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 1.3 · 699 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.3 · 921 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.7 (3.9 to 8.1) · 226 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 12.6 (9.4 to 16.5) · 226 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.4 · 94 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 11.4 · 54 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.3 · 242 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.2 (9.9 to 17.4) · 702 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.7 to 1.4) · 195 cases | No different | Jan 2024 – Dec 2024 |
What patients said (4,032 patients answered, 29% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 2 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 70% |
| Nurses "always" communicated well | 73% |
| Doctors "always" communicated well | 76% |
| Staff "always" explained | 57% |
| Yes, staff "did" give patients this information | 82% |
| Yes, staff "did" give patients information about help after discharge | 82% |
| Doctors "always" explained things so they could understand | 71% |
| Doctors "always" listened carefully | 74% |
| Doctors "always" treated them with courtesy and respect | 82% |
| Patients who gave a rating of "9" or "10" (high) | 67% |
| Staff "always" explained new medications | 71% |
| Nurses "always" explained things so they could understand | 71% |
| Nurses "always" listened carefully | 69% |
| Nurses "always" treated them with courtesy and respect | 80% |
| "Always" quiet at night | 43% |
| "YES", patients would definitely recommend the hospital | 70% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 83% |
Original Medicare doctor bills
$5,065
Medicare paid this office $5,065 for 73 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Short return visit (20+ min) | 20 | $1,844 | $74 |
| X-ray of chest, 2 views | 21 | $262 | $12 |
Who their Medicare patients are
73 Original Medicare patients in 2024. Average age 72 · Women 56% · Also on Medicaid 85% · Health risk score 1.53. At or below the middle of the specialty; the typical pulmonary disease clinician is at 2.13.
Conditions among them: High blood pressure 74% · Diabetes 47% · COPD 26% · Chronic kidney disease 19% · Coronary heart disease 18% · Heart failure 18%.
The office billed $55,003, Medicare allowed $8,052 and paid $5,065; for 105 services of 20 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 73 | 105 | 72 | 1.53 | $55,003 | $5,065 |
| 2023 | 57 | 84 | 72 | 1.62 | $40,419 | $2,737 |
| 2022 | 32 | 45 | 71 | 0.82 | $18,645 | $686 |
| 2021 | 24 | 35 | 73 | 0.80 | $16,864 | $574 |
| 2020 | 12 | 14 | 71 | 1.59 | $5,499 | $212 |
| 2019 | 54 | 163 | 77 | 2.94 | $33,449 | $15,844 |
| 2018 | 226 | 876 | 76 | 3.54 | $178,863 | $83,299 |
| 2017 | 358 | 1,695 | 77 | 3.22 | $293,138 | $148,851 |
| 2016 | 419 | 1,792 | 76 | 3.35 | $350,681 | $155,747 |
| 2015 | 502 | 2,266 | 78 | 3.23 | $530,737 | $189,338 |
| 2014 | 523 | 2,806 | 77 | 2.87 | $411,093 | $223,663 |
| 2013 | 473 | 2,874 | 78 | 2.73 | $314,256 | $180,797 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 1 service
| X-ray of chest, 2 views | 17 | $248 | $15 |
2022: 1 service
| Routine electrocardiogram (ecg) using at least 12 leads with tracing | 12 | $73 | $6 |
2019: 3 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 21 | $4,737 | $88 |
| Critical care, first 30-74 minutes | 14 | $3,980 | $166 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 19 | $3,269 | $62 |
2018: 5 services
| Critical care, first 30-74 minutes | 78 | $28,702 | $174 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 106 | $24,843 | $83 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 84 | $14,669 | $58 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 54 | $6,991 | $109 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 31 | $5,194 | $162 |
2017: 11 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 157 | $36,460 | $85 |
| Critical care, first 30-74 minutes | 90 | $33,703 | $176 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 140 | $32,739 | $60 |
| Return visit (30+ min) | 93 | $20,411 | $86 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 81 | $10,375 | $113 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 43 | $6,918 | $161 |
| New patient visit (45+ min) | 18 | $2,244 | $125 |
| Short return visit (20+ min) | 22 | $2,176 | $59 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 17 | $184 | $11 |
| Test to determine lung volumes using sensors | 17 | $174 | $10 |
| Test to examine how well the lungs exchange gases | 17 | $129 | $8 |
2016: 12 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 182 | $38,649 | $61 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 162 | $36,073 | $88 |
| Critical care, first 30-74 minutes | 84 | $30,279 | $185 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 128 | $18,188 | $117 |
| Return visit (30+ min) | 85 | $17,631 | $92 |
| New patient visit (45+ min) | 27 | $3,892 | $144 |
| Short return visit (20+ min) | 42 | $3,787 | $57 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 13 | $2,419 | $173 |
| Hospital discharge day management, 30 minutes or less | 11 | $687 | $62 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 18 | $201 | $11 |
| Test to determine lung volumes using sensors | 18 | $190 | $10 |
| Test to examine how well the lungs exchange gases | 18 | $141 | $7 |
2015: 12 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 308 | $59,783 | $61 |
| Critical care, first 30-74 minutes | 106 | $47,717 | $189 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 156 | $34,663 | $88 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 171 | $21,631 | $114 |
| Return visit (30+ min) | 70 | $10,911 | $89 |
| Short return visit (20+ min) | 56 | $5,333 | $52 |
| New patient visit (45+ min) | 20 | $2,726 | $136 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 26 | $2,213 | $32 |
| Hospital discharge day management, 30 minutes or less | 11 | $808 | $62 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 24 | $242 | $10 |
| Test to determine lung volumes using sensors | 23 | $218 | $9 |
| Test to examine how well the lungs exchange gases | 23 | $162 | $7 |
2014: 13 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 257 | $74,869 | $61 |
| Critical care, first 30-74 minutes | 135 | $53,809 | $187 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 169 | $48,679 | $88 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 133 | $17,691 | $115 |
| Short return visit (20+ min) | 68 | $10,188 | $56 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 77 | $6,611 | $33 |
| Return visit (30+ min) | 33 | $3,958 | $94 |
| New patient visit (45+ min) | 21 | $2,970 | $141 |
| Administration of influenza virus vaccine | 17 | $466 | $27 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 22 | $257 | $11 |
| Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (fluvirin) | 17 | $257 | $15 |
| Test to determine lung volumes using sensors | 23 | $253 | $11 |
| Test to examine how well the lungs exchange gases | 22 | $180 | $8 |
2013: 12 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 302 | $78,567 | $60 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 120 | $36,407 | $86 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 182 | $23,266 | $114 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 127 | $16,781 | $32 |
| Short return visit (20+ min) | 79 | $9,628 | $57 |
| Return visit (30+ min) | 41 | $4,405 | $90 |
| Critical care, first 30-74 minutes | 22 | $4,397 | $183 |
| New patient visit (45+ min) | 20 | $2,752 | $138 |
| Hospital discharge day management, 30 minutes or less | 20 | $1,523 | $61 |
| Test to determine lung volumes using sensors | 36 | $397 | $11 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 36 | $395 | $11 |
| Test to examine how well the lungs exchange gases | 36 | $291 | $8 |
Medicaid work
$238,179 in 2024
Medicaid paid $238,179 for 5,621 billed services this clinician did in 2024, up to 117 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Clinic visit/encounter, all-inclusive | 513 | $230,332 |
| Federally qualified health center (fqhc) visit, established patient; a medically-necessary, face-to-face encounter (one-on-one) between an established patient and a fqhc practitioner during which time one or more fqhc services are rendered and includes a typical bundle of medicare-covered services that would be furnished per diem to a patient receiving a fqhc visit | 16 | $5,864 |
| Short return visit (20+ min) | 1,512 | $1,983 |
| Pain severity quantified; pain present (COA) (ONC) | 177 | $0 |
| Pain severity quantified; no pain present (COA) (ONC) | 142 | $0 |
| Medication list documented in medical record (COA) | 728 | $0 |
| Review of all medications by a prescribing practitioner or clinical pharmacist (such as, prescriptions, OTCs, herbal therapies and supplements) documented in the medical record (COA) | 140 | $0 |
| Most recent systolic blood pressure less than 130 mm Hg (DM) (HTN, CKD, CAD) | 798 | $0 |
| Most recent systolic blood pressure 130-139 mm Hg (DM) (HTN, CKD, CAD) | 229 | $0 |
| Most recent systolic blood pressure greater than or equal to 140 mm Hg (HTN, CKD, CAD) (DM) | 172 | $0 |
| Most recent diastolic blood pressure less than 80 mm Hg (HTN, CKD, CAD) (DM) | 985 | $0 |
| Most recent diastolic blood pressure 80-89 mm Hg (HTN, CKD, CAD) (DM) | 196 | $0 |
| 2024 | 5,621 | 13 | 117 | $238,179 |
| 2023 | 3,009 | 12 | 109 | $346,522 |
| 2022 | 4,773 | 11 | 118 | $436,654 |
| 2021 | 3,773 | 11 | 115 | $500,964 |
| 2020 | 1,357 | 5 | 59 | $183,434 |
| 2019 | 121 | 2 | 27 | $14,256 |
See the largest Medicaid services in earlier years
2023
| Clinic visit/encounter, all-inclusive | 781 | $342,781 |
| Short return visit (20+ min) | 1,605 | $3,700 |
| Blood count; complete (CBC), automated (Hgb, Hct, RBC, WBC and platelet count) and automated differential WBC count | 17 | $17 |
| ELECTROLYTE PANEL | 16 | $9 |
| Creatinine; blood | 16 | $6 |
| Blood glucose (sugar) level | 16 | $5 |
| Urea nitrogen; quantitative | 16 | $5 |
| Most recent hemoglobin A1c (HbA1c) level less than 7.0% (DM) | 45 | $0 |
| Most recent systolic blood pressure less than 130 mm Hg (DM) (HTN, CKD, CAD) | 221 | $0 |
| Most recent systolic blood pressure 130-139 mm Hg (DM) (HTN, CKD, CAD) | 13 | $0 |
| Most recent diastolic blood pressure less than 80 mm Hg (HTN, CKD, CAD) (DM) | 251 | $0 |
| Most recent diastolic blood pressure 80-89 mm Hg (HTN, CKD, CAD) (DM) | 12 | $0 |
2022
| Clinic visit/encounter, all-inclusive | 1,039 | $431,346 |
| Short return visit (20+ min) | 1,788 | $4,304 |
| Short return visit | 346 | $817 |
| Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); 1 vaccine (single or combination vaccine/toxoid) | 177 | $95 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 50 | $92 |
| Most recent hemoglobin A1c (HbA1c) level less than 7.0% (DM) | 167 | $0 |
| Most recent systolic blood pressure less than 130 mm Hg (DM) (HTN, CKD, CAD) | 401 | $0 |
| Most recent systolic blood pressure 130-139 mm Hg (DM) (HTN, CKD, CAD) | 127 | $0 |
| Most recent systolic blood pressure greater than or equal to 140 mm Hg (HTN, CKD, CAD) (DM) | 78 | $0 |
| Most recent diastolic blood pressure less than 80 mm Hg (HTN, CKD, CAD) (DM) | 468 | $0 |
| Most recent diastolic blood pressure 80-89 mm Hg (HTN, CKD, CAD) (DM) | 132 | $0 |
2021
| Clinic visit/encounter, all-inclusive | 1,171 | $498,012 |
| Short return visit (20+ min) | 1,143 | $1,884 |
| Short return visit | 875 | $1,028 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 17 | $26 |
| Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); 1 vaccine (single or combination vaccine/toxoid) | 17 | $14 |
| Most recent hemoglobin A1c (HbA1c) level less than 7.0% (DM) | 106 | $0 |
| Most recent systolic blood pressure less than 130 mm Hg (DM) (HTN, CKD, CAD) | 173 | $0 |
| Most recent systolic blood pressure 130-139 mm Hg (DM) (HTN, CKD, CAD) | 23 | $0 |
| Most recent systolic blood pressure greater than or equal to 140 mm Hg (HTN, CKD, CAD) (DM) | 24 | $0 |
| Most recent diastolic blood pressure less than 80 mm Hg (HTN, CKD, CAD) (DM) | 201 | $0 |
| Most recent diastolic blood pressure 80-89 mm Hg (HTN, CKD, CAD) (DM) | 23 | $0 |
2020
| Clinic visit/encounter, all-inclusive | 527 | $182,808 |
| Payment for communication technology-based services for 5 minutes or more of a virtual (non-face-to-face) communication between an rural health clinic (rhc) or federally qualified health center (fqhc) practitioner and rhc or fqhc patient, or 5 minutes or more of remote evaluation of recorded video and/or images by an rhc or fqhc practitioner, occurring in lieu of an office visit; rhc or fqhc only | 51 | $341 |
| Short return visit | 303 | $285 |
| Short return visit (20+ min) | 391 | $0 |
| Telephone evaluation and management service by a physician or other qualified health care professional who may report evaluation and management services provided to an established patient, parent, or guardian not originating from a related E/M service provided within the previous 7 days nor leading to an E/M service or procedure within the next 24 hours or soonest available appointment; 5-10 minutes of medical discussion | 85 | $0 |
2019
| Clinic visit/encounter, all-inclusive | 42 | $14,178 |
| Short return visit (20+ min) | 79 | $78 |
Drugs they prescribed that Part D paid
$46,007
Pharmacies billed $46,007 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 422) in 2024. At or below the middle of the specialty; the typical pulmonary disease clinician is at 0%.
311 generic and fewer than 11 brand-name prescriptions · $46,007 in drug cost · 39 antibiotic prescriptions to 37 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Eliquis | 12 | $8,096 | $675 |
| Anoro Ellipta | 12 | $5,131 | $428 |
| Albuterol Sulfate Hfa | 32 | $1,070 | $33 |
| Atorvastatin | 25 | $143 | $6 |
| Metformin | 12 | $77 | $6 |
See all 9 drugs
| Eliquis | 12 | $8,096 | $675 |
| Anoro Ellipta | 12 | $5,131 | $428 |
| Albuterol Sulfate Hfa | 32 | $1,070 | $33 |
| Atorvastatin | 25 | $143 | $6 |
| Metformin | 12 | $77 | $6 |
| Azithromycin | 19 | $53 | $3 |
| Amlodipine Besylate | 18 | $36 | $2 |
| Ibuprofen | 12 | $28 | $2 |
| Baclofen | 13 | $28 | $2 |
Year by year
| 2024 | 422 | 155 | 0% (0) | None | $46,007 |
| 2023 | 283 | 137 | 0% (0) | None | $22,109 |
| 2022 | 359 | 152 | 0% (0) | None | $26,961 |
| 2021 | 238 | 132 | 0% (0) | None | $9,854 |
| 2020 | 278 | 106 | 0% (0) | 18% | $21,917 |
| 2019 | 210 | 34 | 0% (0) | 26% | $28,699 |
| 2018 | 401 | 56 | 0% (0) | None | $70,653 |
| 2017 | 847 | 98 | None | None | $119,128 |
| 2016 | 974 | 121 | None | None | $166,771 |
| 2015 | 873 | 120 | None | None | $124,094 |
| 2014 | 815 | 115 | 0% (0) | None | $98,581 |
| 2013 | 823 | 107 | None | None | $94,058 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 6 drugs
| Albuterol Sulfate Hfa | 11 | $478 | $43 |
| Atorvastatin | 16 | $370 | $23 |
| Losartan | 13 | $328 | $25 |
| Amlodipine Besylate | 12 | $244 | $20 |
| Levothyroxine | 11 | $227 | $21 |
| Azithromycin | 14 | $76 | $5 |
2022: 5 drugs
| Albuterol Sulfate Hfa | 11 | $594 | $54 |
| Atorvastatin | 27 | $428 | $16 |
| Amlodipine Besylate | 30 | $282 | $9 |
| Diclofenac | 14 | $209 | $15 |
| Ibuprofen | 13 | $32 | $2 |
2021: 5 drugs
| Nitrofurantoin Mono-Macro | 12 | $159 | $13 |
| Triamcinolone Acetonide | 11 | $68 | $6 |
| Amlodipine Besylate | 11 | $65 | $6 |
| Naproxen | 16 | $44 | $3 |
| Ibuprofen | 14 | $39 | $3 |
2020: 4 drugs
| Atorvastatin | 15 | $186 | $12 |
| Metformin | 11 | $170 | $15 |
| Amlodipine Besylate | 20 | $141 | $7 |
| Azithromycin | 22 | $133 | $6 |
2019: 5 drugs
| Novolin R | 15 | $2,094 | $140 |
| Atorvastatin | 13 | $258 | $20 |
| Amlodipine Besylate | 30 | $208 | $7 |
| Simvastatin | 11 | $199 | $18 |
| Metformin | 13 | $180 | $14 |
2018: 8 drugs
| Advair Diskus | 30 | $23,098 | $770 |
| Symbicort | 17 | $5,542 | $326 |
| Novolin R | 15 | $2,101 | $140 |
| Atorvastatin | 25 | $601 | $24 |
| Montelukast | 17 | $366 | $22 |
| Simvastatin | 20 | $336 | $17 |
| Metformin | 22 | $268 | $12 |
| Amlodipine Besylate | 37 | $256 | $7 |
2017: 28 drugs
| Advair Diskus | 62 | $42,181 | $680 |
| Symbicort | 39 | $11,890 | $305 |
| Spiriva Respimat | 13 | $7,492 | $576 |
| Breo Ellipta | 13 | $4,182 | $322 |
| Novolin R | 11 | $1,561 | $142 |
| Ventolin Hfa | 29 | $1,530 | $53 |
| Amantadine | 11 | $1,513 | $138 |
| Proair Hfa | 20 | $1,427 | $71 |
| Atorvastatin | 52 | $940 | $18 |
| Montelukast | 38 | $817 | $21 |
| Valsartan | 16 | $585 | $37 |
| Enalapril Maleate | 11 | $451 | $41 |
| Synthroid | 12 | $408 | $34 |
| Metoprolol | 13 | $377 | $29 |
| Levothyroxine | 18 | $341 | $19 |
| Metformin | 41 | $331 | $8 |
| Triamterene-Hydrochlorothiazid | 15 | $300 | $20 |
| Amlodipine Besylate | 49 | $298 | $6 |
| Prednisone | 29 | $216 | $7 |
| Fluticasone Propionate | 13 | $205 | $16 |
| Ramipril | 12 | $181 | $15 |
| Simvastatin | 19 | $172 | $9 |
| Potassium Chloride | 11 | $169 | $15 |
| Benazepril | 15 | $134 | $9 |
| Lisinopril | 18 | $115 | $6 |
| Azithromycin | 11 | $104 | $9 |
| Furosemide | 20 | $70 | $4 |
| Alendronate | 14 | $51 | $4 |
2016: 25 drugs
| Advair Diskus | 70 | $36,274 | $518 |
| Januvia | 34 | $20,542 | $604 |
| Spiriva | 32 | $13,932 | $435 |
| Symbicort | 32 | $9,903 | $309 |
| Flovent Hfa | 11 | $2,685 | $244 |
| Proair Hfa | 39 | $2,339 | $60 |
| Humulin R | 13 | $1,753 | $135 |
| Montelukast | 54 | $1,290 | $24 |
| Ventolin Hfa | 23 | $1,195 | $52 |
| Atorvastatin | 47 | $988 | $21 |
| Metformin | 55 | $816 | $15 |
| Valsartan | 12 | $793 | $66 |
| Amlodipine Besylate | 53 | $675 | $13 |
| Tamsulosin | 12 | $612 | $51 |
| Synthroid | 11 | $532 | $48 |
| Metoprolol | 12 | $367 | $31 |
| Prednisone | 37 | $312 | $8 |
| Triamterene-Hydrochlorothiazid | 20 | $307 | $15 |
| Levothyroxine | 15 | $283 | $19 |
| Azithromycin | 16 | $221 | $14 |
| Simvastatin | 21 | $216 | $10 |
| Ramipril | 21 | $197 | $9 |
| Lisinopril | 15 | $168 | $11 |
| Alendronate | 14 | $51 | $4 |
| Furosemide | 11 | $27 | $2 |
2015: 24 drugs
| Advair Diskus | 60 | $31,366 | $523 |
| Spiriva | 43 | $21,138 | $492 |
| Symbicort | 58 | $18,738 | $323 |
| Januvia | 13 | $11,244 | $865 |
| Levemir | 11 | $5,612 | $510 |
| Valsartan | 17 | $4,174 | $246 |
| Flovent Hfa | 13 | $2,633 | $203 |
| Proair Hfa | 40 | $2,117 | $53 |
| Humulin R | 14 | $1,662 | $119 |
| Montelukast | 57 | $1,222 | $21 |
| Atorvastatin | 34 | $881 | $26 |
| Synthroid | 11 | $492 | $45 |
| Pioglitazone | 11 | $469 | $43 |
| Levothyroxine | 15 | $341 | $23 |
| Metformin | 46 | $283 | $6 |
| Lisinopril | 26 | $230 | $9 |
| Amlodipine Besylate | 41 | $227 | $6 |
| Allopurinol | 11 | $214 | $19 |
| Prednisone | 26 | $194 | $7 |
| Azithromycin | 19 | $193 | $10 |
| Triamterene-Hydrochlorothiazid | 20 | $167 | $8 |
| Simvastatin | 20 | $149 | $7 |
| Ramipril | 18 | $142 | $8 |
| Warfarin | 11 | $123 | $11 |
2014: 22 drugs
| Advair Diskus | 62 | $24,404 | $394 |
| Spiriva | 43 | $17,515 | $407 |
| Symbicort | 38 | $12,129 | $319 |
| Diovan | 23 | $5,087 | $221 |
| Flovent Hfa | 12 | $2,251 | $188 |
| Humulin R | 14 | $1,435 | $102 |
| Atorvastatin | 30 | $860 | $29 |
| Montelukast | 47 | $826 | $18 |
| Synthroid | 16 | $797 | $50 |
| Proair Hfa | 14 | $754 | $54 |
| Potassium Chloride | 14 | $378 | $27 |
| Ramipril | 20 | $356 | $18 |
| Lisinopril | 28 | $313 | $11 |
| Amlodipine Besylate | 44 | $311 | $7 |
| Fluticasone Propionate | 12 | $282 | $24 |
| Metformin | 26 | $277 | $11 |
| Simvastatin | 24 | $256 | $11 |
| Triamterene-Hydrochlorothiazid | 25 | $238 | $10 |
| Prednisone | 29 | $236 | $8 |
| Azithromycin | 13 | $142 | $11 |
| Allopurinol | 12 | $96 | $8 |
| Furosemide | 14 | $28 | $2 |
2013: 23 drugs
| Advair Diskus | 43 | $20,819 | $484 |
| Spiriva | 40 | $18,558 | $464 |
| Symbicort | 46 | $13,600 | $296 |
| Diovan | 26 | $5,031 | $194 |
| Crestor | 12 | $4,683 | $390 |
| Montelukast | 70 | $2,771 | $40 |
| Flovent Hfa | 12 | $2,006 | $167 |
| Atorvastatin | 28 | $1,344 | $48 |
| Proair Hfa | 28 | $1,313 | $47 |
| Humulin R | 13 | $1,091 | $84 |
| Fluticasone Propionate | 13 | $613 | $47 |
| Amlodipine Besylate | 43 | $475 | $11 |
| Metformin | 24 | $365 | $15 |
| Synthroid | 15 | $361 | $24 |
| Warfarin | 16 | $316 | $20 |
| Simvastatin | 20 | $303 | $15 |
| Azithromycin | 20 | $289 | $14 |
| Lisinopril | 26 | $275 | $11 |
| Prednisone | 35 | $185 | $5 |
| Metoprolol | 12 | $152 | $13 |
| Levofloxacin | 15 | $136 | $9 |
| Benazepril | 11 | $113 | $10 |
| Triamterene-Hctz | 13 | $103 | $8 |
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 80.6 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1679511315
- Licence
- CA A42385California A42385: Current · expires 2027-05-31
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207RP1001X (207RP1001X)
- Mailing address
- 11180 Warner Ave, Suite 253, Fountain Valley, CA, 92708
- NPI first listed
- 2006-06-03
- NPI last updated
- 2013-04-24
This is when the NPI record was last certified, not a medical board exam.